To date, the jury is still out and investigations to associate APJ signaling with in vivo phenotypic cardiovascular and renal functions is a conundrum that will have to be solved with the help of biased agonists demonstrating beneficial therapeutic impacts and reduced undesired activities in sepsis. Here, APLNR is linked to Sepsis.